Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain. - Braden K; Stratton HJ; Salvemini D; Khanna R (Neurobiology of pain (Cambridge, Mass.), 2021)